Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential
Overview
Authors
Affiliations
Galectin-1 (Gal-1)-binding to Gal-1 ligands on immune and endothelial cells can influence melanoma development through dampening antitumor immune responses and promoting angiogenesis. However, whether Gal-1 ligands are functionally expressed on melanoma cells to help control intrinsic malignant features remains poorly understood. Here, we analyzed expression, identity, and function of Gal-1 ligands in melanoma progression. Immunofluorescent analysis of benign and malignant human melanocytic neoplasms revealed that Gal-1 ligands were abundant in severely dysplastic nevi, as well as in primary and metastatic melanomas. Biochemical assessments indicated that melanoma cell adhesion molecule (MCAM) was a major Gal-1 ligand on melanoma cells that was largely dependent on its N-glycans. Other melanoma cell Gal-1 ligand activity conferred by O-glycans was negatively regulated by α2,6 sialyltransferase ST6GalNAc2. In Gal-1-deficient mice, MCAM-silenced (MCAM(KD)) or ST6GalNAc2-overexpressing (ST6(O/E)) melanoma cells exhibited slower growth rates, underscoring a key role for melanoma cell Gal-1 ligands and host Gal-1 in melanoma growth. Further analysis of MCAM(KD) or ST6(O/E) melanoma cells in cell migration assays indicated that Gal-1 ligand-dependent melanoma cell migration was severely inhibited. These findings provide a refined perspective on Gal-1/melanoma cell Gal-1 ligand interactions as contributors to melanoma malignancy.
Glycosylation in the tumor immune response: the bitter side of sweetness.
Cao Y, Yi W, Zhu Q Acta Biochim Biophys Sin (Shanghai). 2024; 56(8):1184-1198.
PMID: 38946426 PMC: 11399423. DOI: 10.3724/abbs.2024107.
Zhang L, Chen W, Li X, Wang G, Xing F, Zhu X Cell Adh Migr. 2024; 18(1):1-11.
PMID: 38557441 PMC: 10986763. DOI: 10.1080/19336918.2024.2335881.
Galectin functions in cancer-associated inflammation and thrombosis.
Kruk L, Braun A, Cosset E, Gudermann T, Mammadova-Bach E Front Cardiovasc Med. 2023; 10:1052959.
PMID: 36873388 PMC: 9981828. DOI: 10.3389/fcvm.2023.1052959.
Batts T, Sasaki E, Miller M, Sparago J, Bauer R, Paulsen D PLoS One. 2023; 18(1):e0280928.
PMID: 36696389 PMC: 9876354. DOI: 10.1371/journal.pone.0280928.
Lau L, Mohammed N, Dimitroff C Int J Mol Sci. 2022; 23(24).
PMID: 36555198 PMC: 9778980. DOI: 10.3390/ijms232415554.